Composition that comprises at least one oxime and its use in therapeutics
AssigneeSerb SA
InventorsFrederic BAUD, Pascal HOUZE, Maya KAYOUKA
Life of this patent
Estimating the term…
Abstract
This invention relates to a medication, a pharmaceutical composition. and method for the treatment of respiratory poisoning in animals and humans caused by organophosphorus compounds, whereby said medication and said pharmaceutical composition comprise at least one oxime and one blocker of organic cation transporters (OCT).
Claims18
Method for the treatment of respiratory poisoning in animals and humans caused by organophosphorus compounds, comprising the blocking of organic cation transporters at the renal level (OCT) and the administration of an effective amount of at least one oxime.
Medication that comprises at least one oxime and at least one agent that blocks the OCT as active ingredients.
Pharmaceutical composition that comprises at least one oxime and at least one agent that blocks the OCT as active ingredients as well as at least one pharmaceutically acceptable vehicle.
Dependencies are inferred from the claim text.